19 June 2024
\n \n \n \nChrystalina Antoniades is an Associate Professor of Clinical Neuroscience at the Nuffield Department of Clinical Neurosciences. In her story, Chrystalina shares her experience of collaboration and her top tips for successfully working with industry - ensuring mutual alignment and showcasing your passion.
\n \n\n \n \n17 May 2024
\n \n \n \nProfessor Heidi Johansen-Berg, Professor of Cognitive Neuroscience has been honoured by the Royal Society by being elected a Fellow for her outstanding contributions to science.
\n \n\n \n \n25 April 2024
\n \n \n \nResearchers from the NDCN have used data from UK Biobank participants to reveal that diabetes, traffic-related air pollution and alcohol intake are the most harmful out of 15 modifiable risk factors for dementia.
\n \n\n \n \n27 March 2024
\n \n \n \nWho has been awarded a prestigious fellowship.
\n \n\n \n \n19 February 2024
\n \n \n \nDr Henrietta Hughes, the Patient Safety Commissioner for England, visited the Oxford Simulation, Teaching and Research Centre (OxSTaR) at the John Radcliffe Hospital on Friday 16 February.
\n \n\n \n \n12 February 2024
\n \n \n \nAn in-depth economic analysis by a multi-national research group has concluded that the productivity gained by using Anaesthesia Associates in operating theatres are very modest and do not justify the salaries currently being paid.
\n \n\n \n \n5 February 2024
\n \n \n \nThe Cognitive Neurology Research Group at the Nuffield Department of Clinical Neurosciences has shown that remote digital cognitive testing can detect subtle cognitive impairments in chronic autoimmune limbic encephalitis (ALE) patients.
\n \n\n \n \n18 January 2024
\n \n \n \nResearchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Department of Clinical Neurosciences have identified a novel mechanism by which the brain produces powerful lasting memories that drive ill-advised actions. Focusing on cocaine experience, the researchers demonstrate how the collective activity of many nerve cells distributed across the brain underlies the persistence of such memories, providing new insights into why drug-seeking behaviours could lead to addiction.
\n \n\n \n \n11 January 2024
\n \n \n \nResearch led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists\u2019 view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
\n \n\n \n \n3 January 2024
\n \n \n \nResearchers from the MRC Brain Network Dynamics Unit and Oxford University's Department of Computer Science have set out a new principle to explain how the brain adjusts connections between neurons during learning.
\n \n\n \n \n18 December 2023
\n \n \n \nOur researchers have shown for the first time non-invasively in humans a differential, clinically meaningful impact of Huntington\u2019s and Parkinson\u2019s diseases on the sensorimotor functional connection of the subthalamic nucleus and sensorimotor cortex.
\n \n\n \n \n5 December 2023
\n \n \n \nResearch carried out at the University of Oxford has led to the development of a new blood-based test to identify the pathology that triggers Parkinson\u2019s disease before the main symptoms occur. This could allow clinicians to screen for those individuals at high risk of developing the disease and facilitate the timely introduction of precision therapies that are currently at clinical trial stage.
\n \n\n \n \n7 November 2023
\n \n \n \nNDCN hosted a networking event with a delegation from the Finnish embassy and a group of University of Oxford students from Finland.
\n \n\n \n \n30 October 2023
\n \n \n \n\n \n \n9 October 2023
\n \n \n \nA team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson\u2019s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
\n \n\n \n \n5 October 2023
\n \n \n \nOur researchers have shown the potential of a new gene therapy approach to silence human sensory neurons as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
\n \n\n \n \n8 September 2023
\n \n \n \nMany congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
\n \n\n \n \n7 September 2023
\n \n \n \nPAINCAST: Neuropathic Pain Unravelled, a creative podcast about living with long-term pain, is part of a ground-breaking four-year collaborative research project into neuropathic pain.
\n \n\n \n \n5 September 2023
\n \n \n \nMuscular Dystrophy UK has announced that it is investing \u00a31.3 million into 11 new research projects including one at the University of Oxford.
\n \n\n \n \n11 August 2023
\n \n \n \nResearchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
\n \n\n \n \n